| 000 | 01550 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513184911.0 | ||
| 264 | 0 | _c19990708 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0270-4137 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0045(19990701)40:2<125::aid-pros8>3.0.co;2-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTjoa, B A | |
| 245 | 0 | 0 |
_aFollow-up evaluation of a phase II prostate cancer vaccine trial. _h[electronic resource] |
| 260 |
_bThe Prostate _cJul 1999 |
||
| 300 |
_a125-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntigens, Surface |
| 650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboxypeptidases _ximmunology |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 | _aGlutamate Carboxypeptidase II |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 | _aLeukapheresis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _ximmunology |
| 700 | 1 | _aSimmons, S J | |
| 700 | 1 | _aElgamal, A | |
| 700 | 1 | _aRogers, M | |
| 700 | 1 | _aRagde, H | |
| 700 | 1 | _aKenny, G M | |
| 700 | 1 | _aTroychak, M J | |
| 700 | 1 | _aBoynton, A L | |
| 700 | 1 | _aMurphy, G P | |
| 773 | 0 |
_tThe Prostate _gvol. 40 _gno. 2 _gp. 125-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0045(19990701)40:2<125::aid-pros8>3.0.co;2-y _zAvailable from publisher's website |
| 999 |
_c10344816 _d10344816 |
||